India sticks to AstraZeneca vaccine ‘with full vigour’

Government expert says India’s health ministry is aware of potential blood clot issue but he had ‘no concern at all’.

India is not worried about some European Union countries suspending use of the AstraZeneca COVID-19 vaccine and will continue to roll out the shot in its huge immunisation programme “with full vigour”, a senior official said. The AstraZeneca shots are produced by India’s Serum Institute and known in the country as Covishield. The vaccine accounts for most of the 35 million coronavirus jabs administered in the country so far. But the European nations, including France, Spain and Germany, have suspended the vaccine’s use because of worries it causes blood clots.